About Publications

Publications from the National Academies of Sciences, Engineering, and Medicine provide objective and straightforward advice to decision makers and the public. This site includes Health and Medicine Division (HMD) publications released after 1998. A complete list of HMD’s publications from its establishment in 1970 to the present is available as a PDF.

  • HHS in the 21st Century: Charting a New Course for a ... Released: December 09, 2008
    The U.S. Department of Health and Human Services (HHS)—which boasts the largest budget of any federal department, spending approximately 2 billion dollars a day—profoundly affects the lives of all Americans. At the request of the U.S. House of Representatives Committee on Oversight and Government Reform, the IOM’s December 2008 report HHS in the 21st Century assesses whether HHS is “ideally organized” to meet the enduring and emerging health challenges facing our nation.
  • Evidence-Based Medicine and the Changing Nature of ... Released: October 09, 2008
    Drawing on the work of the Roundtable on Evidence-Based Medicine, the 2007 IOM Annual Meeting assessed some of the rapidly occurring changes in health care related to new diagnostic and treatment tools, emerging genetic insights, the developments in information technology, and healthcare costs, and discussed the need for a stronger focus on evidence to ensure that the promise of scientific discovery and technological innovation is efficiently captured to provide the right care for the right patient at the right time.
  • The Richard and Hinda Rosenthal Lecture 2007 ... Released: March 20, 2008
    The 2007 Rosenthal Lecture featured a panel talk on Transforming Today’s Health Care Workforce to Meet Tomorrow’s Demands
  • The Learning Healthcare System : Health and Medicine ... Released: March 30, 2007
    The Roundtable serves as a neutral venue for cooperative work among key stakeholders on several dimensions: to help transform the availability and use of the best evidence for the collaborative health care choices of each patient and provider; to drive the process of discovery as a natural outgrowth of patient care; and, ultimately, to ensure innovation, quality, safety, and value in health care.
  • Implementing Cancer Survivorship Care Planning: Workshop ... Released: December 22, 2006
    The IOM Committee on Cancer Survivorship: Improving Care and Quality of Life concluded in their 2006 report "From Cancer Patient to Cancer Survivor: Lost in Transition" that cancer survivorship is a distinct phase of the cancer trajectory and that a strategy is needed for the ongoing clinical care of cancer survivors. As a follow-up to the report, the National Cancer Policy Forum of the Institute of Medicine (IOM) held a workshop, "Implementing Cancer Survivorship Care Planning" May 15-16 in Washington DC.
  • The Richard and Hinda Rosenthal Lecture 2005: Next Steps ... Released: October 12, 2006
    The 2005 Rosenthal Lecture featured a panel talk on the Next Steps Toward Higher Qualtiy Health Care.
  • The Richard and Hinda Rosenthal Lecture 2004: Perspectives ... Released: November 14, 2005
    The 2004 Rosenthal Lecture featured a panel talk on the IOM report, Preventing Childhood Obesity: Health in the Balance.
  • From Cancer Patient to Cancer Survivor: Lost in Transition ... Released: November 03, 2005
    Citing shortfalls in the care currently provided to the country's 10 million cancer survivors, From Cancer Patient to Cancer Survivor: Lost in Transition recommends that each cancer patient receive a "survivorship care plan."
  • Making Better Drugs for Children with Cancer : Health and ... Released: April 18, 2005
    Continued improvements in survival of childhood and adolescent cancer and less toxic outcomes will be achieved only with new chemical and biological agents. Despite a wealth of tantalizing leads from basic science, there is a near-complete void in commercial R&D for pediatric cancer. There is another way to harness the disparate activities already in existence to discover and develop new drugs for pediatric cancers. Making Better Drugs for Children with Cancer describes a practical approach to joining the capabilities of the National Institutes of Health, academic laboratories, and the pharmaceutical industry in a virtual R&D network.